Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

French JA, Lawson JA, Yapici Z, Ikeda H, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 2016;388:2153-2163.
PMID: 27613521


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016